Photo by Marta Branco
People who take certain blood pressure medications are being urged to check their prescription bottles after a nationwide recall raised concerns about possible metal contamination.
Breckenridge Pharmaceutical Inc. announced a voluntary recall on November 16, 2026, involving one lot of 60 mg propranolol hydrochloride extended-release capsules. The affected capsules may contain metal fragments that could injure soft tissue in the mouth and digestive tract.
The recall applies to a specific lot distributed to wholesalers and pharmacies across the United States. It does not cover every propranolol medication or every manufacturer.
Patients who use this medication should check their bottles and contact their pharmacist or healthcare provider if they have questions about their prescription.
Which propranolol medication is being recalled?
The recall covers Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg. Breckenridge Pharmaceutical distributed the affected product in 100-count bottles.
Patients and caregivers can check the following identifying details:
- Medication: Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg
- Bottle size: 100 capsules
- National Drug Code (NDC): 51991-817-01
- Affected lot number: PK25110035
- Expiration date: May 2029
The company distributed the affected lot to wholesalers and pharmacies nationwide between October 26 and November 4, 2026.
If your pharmacy transferred your prescription into a different container, the manufacturer’s lot number may not appear on your prescription label. In that situation, contact the pharmacy that filled your prescription. The pharmacist can help determine whether your medication came from the recalled lot.
Why did the company recall the capsules?
Breckenridge issued the recall because the affected capsules may contain metal contamination.
According to the company’s announcement, the recalled lot shared intermediate material suspected of being the source of metal contamination found in a separate lot. That other lot was not released to the market.
The company warned that taking capsules from the affected lot could cause lacerations to soft tissues in the oral cavity, esophagus, stomach or intestine.
These injuries may occur if someone swallows metal fragments contained in the medication.
However, Breckenridge said it was not aware of any adverse events assessed to be related to the recall when it issued the announcement.
The company is conducting the voluntary recall with the knowledge of the U.S. Food and Drug Administration (FDA).
What should patients do if they have the recalled medication?
Breckenridge advises consumers to stop taking medication from the affected lot immediately. The company also recommends contacting a physician or healthcare provider for medical advice and replacement instructions.
Patients should return any unused portion of the recalled medication to the pharmacy where they obtained it.
If you take propranolol, contact your pharmacist or prescribing clinician promptly to confirm whether your prescription is affected and arrange an appropriate replacement. Do not independently change your treatment plan or substitute another medication.
This is especially important because propranolol is a beta-blocker. It is prescribed for several conditions, including high blood pressure and certain heart-related problems. Your healthcare provider can help you manage the recall while maintaining appropriate treatment.
Anyone who experiences a health problem they believe may be related to the medication should contact a healthcare professional.
Pharmacies must check their inventory
The recall also affects wholesalers, pharmacies and other retail businesses that handle the medication.
Breckenridge has instructed these businesses to check their inventory for the affected lot. They must quarantine recalled products and stop distributing or dispensing them.
Businesses that supplied the medication to other retailers must also notify those accounts.
Patients who have questions about the recall can contact Qualanex, Breckenridge’s designated recall service provider, at 1-855-736-0807. The service is available Monday through Friday, from 9 a.m. to 5 p.m. Eastern Time.
Consumers can also report suspected medication-related adverse events or product quality problems through the FDA’s MedWatch program at FDA MedWatch.
What patients should remember about the recall
The propranolol recall is limited to one identified lot of 60 mg extended-release capsules. Therefore, checking the lot number is essential before assuming that a prescription is affected.
Patients should not ignore the warning or continue using capsules confirmed to belong to the recalled lot. They should contact their healthcare provider for medical advice and replacement instructions.
For families helping older relatives or people who take several prescriptions, checking medication bottles and contacting the dispensing pharmacy can help prevent confusion.
The company has not reported any adverse events linked to the recall. However, the potential for physical injury makes it important for patients to follow the recall instructions and seek professional guidance.







